Companies / Forte Biosciences, Inc.
Forte Biosciences, Inc.
Nasdaq: FBRXCIK 1419041DALLAS, TX
Financials · FY2019
Ownership
21.2M shares outstanding · as of Aug 7, 2026
Ownership
| Insiders | 0.59% | 125,160 |
| 10%+ / strategic | 5.82% | 1,235,614 |
| Institutions | 64.02% | 13,590,533 |
| Public float | 29.57% | 6,277,780 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Wagner Paul A.SEE REMARKS · Director | 0.39% | 83,178 |
Riley Antony ACHIEF FINANCIAL OFFICER | 0.20% | 41,982 |
Gryska David WDirector | — | — |
Vincent Richard GDirector | — | — |
Institutional holders 62
View all →| Holder | Value | % of shares |
|---|---|---|
| $45.73M | 8.32% | |
| $39.84M | 6.88% | |
| $31.00M | 5.64% | |
| $30.81M | 5.60% | |
| $26.98M | 4.66% | |
| $25.99M | 5.76% | |
| $24.61M | 4.47% | |
| $15.88M | 2.74% | |
| $13.29M | 2.30% | |
| $10.91M | 1.88% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Riley Antony A Executive | Buy | Common Stock | $254.8K | +10K +30.40% | 41,520 0.20% of shares | medium |
| Jan 1, 2026 | Wagner Paul A. Executive | Other | Common Stock | $4.5K | -164 -0.20% | 83,178 0.39% of shares | low |
| Jan 1, 2026 | Riley Antony A Executive | Other | Common Stock | $4.2K | -154 -0.37% | 41,741 0.20% of shares | low |
| Apr 1, 2026 | Riley Antony A Executive | Other | Common Stock | $3.3K | -134 -0.32% | 41,982 0.20% of shares | low |
| Jan 1, 2026 | Wagner Paul A. Executive | Exercise | Common Stock | $0 | +1K +1.52% | 83,342 0.39% of shares | low |
| Jan 1, 2026 | Riley Antony A Executive | Exercise | Common Stock | $0 | +375 +0.90% | 41,895 0.20% of shares | low |
| Jun 16, 2026 | Riley Antony A Executive | Grant | Stock Option (right to buy) | — | +22K | 22,000 0.10% of shares | low |
| Apr 1, 2026 | Riley Antony A Executive | Exercise | Restricted Stock Units | — | -375 -25.00% | 1,125 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Alger Associates, Inc. | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| Oliveira Steven Michael | Passive13G/A | — |
| Affinity Asset Advisors, LLC | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G | — |
| Alger Associates, Inc. | Passive13G/A | — |
| Orbimed Advisors LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| FBRX | — | 34962G208 |